GlassScriptPhysician profile
Gayatri Sarkar
NPI 1376668343
$1,043.45
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.89 · 2020: $70.17 · 2021: $79.62 · 2022: $474 · 2023: $126 · 2024: $138 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.64 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $357.31 | 2019-2022 | |
| Radius Health, INC. | $113.25 | 2022-2024 | Tymlos |
| Amgen INC. | $109.45 | 2023-2025 | Evenity, Tepezza, Prolia |
| Medtronic, INC. | $58.55 | 2021-2023 | Minimed 780g |
| Abbott Laboratories | $57.26 | 2021-2024 | Freestyle Libre 3 |
| Medtronic Minimed, INC. | $53.09 | 2020 | |
| Mannkind Corporation | $42.50 | 2025 | |
| Corcept Therapeutics | $41.34 | 2024-2025 | Korlym |
| Tandem Diabetes Care, INC. | $33.69 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $32.48 | 2024-2025 | Ozempic, Rybelsus |
| Lifescan, INC. | $28.43 | 2021-2022 | |
| Abbvie INC. | $26.89 | 2024 | |
| Recordati_rare_diseases_inc. | $22.76 | 2024 | Isturisa, Signifor Lar |
| Beta Bionics, INC. | $18.76 | 2023 | Ilet Bionic Pancreas |
| Lilly USA, LLC | $18.57 | 2023 | Mounjaro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.08 | 2020 | |
| Dexcom, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gayatri Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.